Endostatin inhibits adhesion of endothelial cells to collagen I via α2β1 integrin, a possible cause of prevention of chondrosarcoma growth

Takayuki Furumatsu, Noriko Yamaguchi, Keiichiro Nishida, Akira Kawai, Toshiyuki Kunisada, Masayoshi Namba, Hajime Inoue, Yoshifumi Ninomiya

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Endostatin derived from collagen XVIII is a potent endogenous anti-angiogenic factor that induces regression of various tumors of epithelial origin. Endostatin has been shown to inhibit endothelial cell functions, however, its effect remains controversial. We first attempted here to apply the inhibitory effect of recombinant human endostatin on chondrosarcomas, which originate from the mesenchyme, in nude mice. Endostatin induced reduction of chondrosarcoma growth and tumor angiogenesis in vivo. However, endostatin showed no effect on the proliferation and migration of chondrosarcoma cells in vitro. Next, we investigated the interactions between endostatin and endothelial cells in detail. Endostatin inhibited the migration on and attachment to collagen I but did not affect the proliferation of endothelial cells. Although the migration of endothelial cells was stimulated by angiogenic factors such as basic fibroblast growth factor and vascular endothelial growth factor, endostatin showed similar inhibitory effects on it in the presence and absence of the stimulants. Moreover, the inhibitory effect against endothelial cell attachment to collagen I was attenuated or modulated in the presence of neutralizing antibodies of α2, α5β1, and αVβ3 integrins but not that of α1 integrin. Our results suggest that endostatin might suppress the α2β1 integrin function of endothelial cells via α5β1 or αVβ3 integrin. We propose here that endostatin might be effective for anti-angiogenic therapy for human chondrosarcomas through the suppression of α2β1 integrin functions in endothelial cells.

Original languageEnglish
Pages (from-to)619-626
Number of pages8
JournalJournal of Biochemistry
Volume131
Issue number4
Publication statusPublished - 2002

Fingerprint

Endostatins
Chondrosarcoma
Endothelial cells
Integrins
Collagen
Adhesion
Endothelial Cells
Growth
Angiogenesis Inducing Agents
Tumors
Collagen Type XVIII
Fibroblast Growth Factor 2
Mesoderm
Neutralizing Antibodies
Nude Mice
Vascular Endothelial Growth Factor A
Cell Movement
Neoplasms

Keywords

  • Basic fibroblast growth factor
  • Chondrosarcoma
  • Endostatin
  • Integrin
  • Tumor angiogenesis

ASJC Scopus subject areas

  • Biochemistry

Cite this

Endostatin inhibits adhesion of endothelial cells to collagen I via α2β1 integrin, a possible cause of prevention of chondrosarcoma growth. / Furumatsu, Takayuki; Yamaguchi, Noriko; Nishida, Keiichiro; Kawai, Akira; Kunisada, Toshiyuki; Namba, Masayoshi; Inoue, Hajime; Ninomiya, Yoshifumi.

In: Journal of Biochemistry, Vol. 131, No. 4, 2002, p. 619-626.

Research output: Contribution to journalArticle

@article{3e847cdca1ab4cb4913059c4cdf9bc9e,
title = "Endostatin inhibits adhesion of endothelial cells to collagen I via α2β1 integrin, a possible cause of prevention of chondrosarcoma growth",
abstract = "Endostatin derived from collagen XVIII is a potent endogenous anti-angiogenic factor that induces regression of various tumors of epithelial origin. Endostatin has been shown to inhibit endothelial cell functions, however, its effect remains controversial. We first attempted here to apply the inhibitory effect of recombinant human endostatin on chondrosarcomas, which originate from the mesenchyme, in nude mice. Endostatin induced reduction of chondrosarcoma growth and tumor angiogenesis in vivo. However, endostatin showed no effect on the proliferation and migration of chondrosarcoma cells in vitro. Next, we investigated the interactions between endostatin and endothelial cells in detail. Endostatin inhibited the migration on and attachment to collagen I but did not affect the proliferation of endothelial cells. Although the migration of endothelial cells was stimulated by angiogenic factors such as basic fibroblast growth factor and vascular endothelial growth factor, endostatin showed similar inhibitory effects on it in the presence and absence of the stimulants. Moreover, the inhibitory effect against endothelial cell attachment to collagen I was attenuated or modulated in the presence of neutralizing antibodies of α2, α5β1, and αVβ3 integrins but not that of α1 integrin. Our results suggest that endostatin might suppress the α2β1 integrin function of endothelial cells via α5β1 or αVβ3 integrin. We propose here that endostatin might be effective for anti-angiogenic therapy for human chondrosarcomas through the suppression of α2β1 integrin functions in endothelial cells.",
keywords = "Basic fibroblast growth factor, Chondrosarcoma, Endostatin, Integrin, Tumor angiogenesis",
author = "Takayuki Furumatsu and Noriko Yamaguchi and Keiichiro Nishida and Akira Kawai and Toshiyuki Kunisada and Masayoshi Namba and Hajime Inoue and Yoshifumi Ninomiya",
year = "2002",
language = "English",
volume = "131",
pages = "619--626",
journal = "Journal of Biochemistry",
issn = "0021-924X",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Endostatin inhibits adhesion of endothelial cells to collagen I via α2β1 integrin, a possible cause of prevention of chondrosarcoma growth

AU - Furumatsu, Takayuki

AU - Yamaguchi, Noriko

AU - Nishida, Keiichiro

AU - Kawai, Akira

AU - Kunisada, Toshiyuki

AU - Namba, Masayoshi

AU - Inoue, Hajime

AU - Ninomiya, Yoshifumi

PY - 2002

Y1 - 2002

N2 - Endostatin derived from collagen XVIII is a potent endogenous anti-angiogenic factor that induces regression of various tumors of epithelial origin. Endostatin has been shown to inhibit endothelial cell functions, however, its effect remains controversial. We first attempted here to apply the inhibitory effect of recombinant human endostatin on chondrosarcomas, which originate from the mesenchyme, in nude mice. Endostatin induced reduction of chondrosarcoma growth and tumor angiogenesis in vivo. However, endostatin showed no effect on the proliferation and migration of chondrosarcoma cells in vitro. Next, we investigated the interactions between endostatin and endothelial cells in detail. Endostatin inhibited the migration on and attachment to collagen I but did not affect the proliferation of endothelial cells. Although the migration of endothelial cells was stimulated by angiogenic factors such as basic fibroblast growth factor and vascular endothelial growth factor, endostatin showed similar inhibitory effects on it in the presence and absence of the stimulants. Moreover, the inhibitory effect against endothelial cell attachment to collagen I was attenuated or modulated in the presence of neutralizing antibodies of α2, α5β1, and αVβ3 integrins but not that of α1 integrin. Our results suggest that endostatin might suppress the α2β1 integrin function of endothelial cells via α5β1 or αVβ3 integrin. We propose here that endostatin might be effective for anti-angiogenic therapy for human chondrosarcomas through the suppression of α2β1 integrin functions in endothelial cells.

AB - Endostatin derived from collagen XVIII is a potent endogenous anti-angiogenic factor that induces regression of various tumors of epithelial origin. Endostatin has been shown to inhibit endothelial cell functions, however, its effect remains controversial. We first attempted here to apply the inhibitory effect of recombinant human endostatin on chondrosarcomas, which originate from the mesenchyme, in nude mice. Endostatin induced reduction of chondrosarcoma growth and tumor angiogenesis in vivo. However, endostatin showed no effect on the proliferation and migration of chondrosarcoma cells in vitro. Next, we investigated the interactions between endostatin and endothelial cells in detail. Endostatin inhibited the migration on and attachment to collagen I but did not affect the proliferation of endothelial cells. Although the migration of endothelial cells was stimulated by angiogenic factors such as basic fibroblast growth factor and vascular endothelial growth factor, endostatin showed similar inhibitory effects on it in the presence and absence of the stimulants. Moreover, the inhibitory effect against endothelial cell attachment to collagen I was attenuated or modulated in the presence of neutralizing antibodies of α2, α5β1, and αVβ3 integrins but not that of α1 integrin. Our results suggest that endostatin might suppress the α2β1 integrin function of endothelial cells via α5β1 or αVβ3 integrin. We propose here that endostatin might be effective for anti-angiogenic therapy for human chondrosarcomas through the suppression of α2β1 integrin functions in endothelial cells.

KW - Basic fibroblast growth factor

KW - Chondrosarcoma

KW - Endostatin

KW - Integrin

KW - Tumor angiogenesis

UR - http://www.scopus.com/inward/record.url?scp=0036242559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036242559&partnerID=8YFLogxK

M3 - Article

C2 - 11927001

AN - SCOPUS:0036242559

VL - 131

SP - 619

EP - 626

JO - Journal of Biochemistry

JF - Journal of Biochemistry

SN - 0021-924X

IS - 4

ER -